📰 Year Analysis News
Page 15 - Year Analysis News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Year Analysis. Real-time updates on events, politics, business and more.
October 10, 2022
Depression impacts many more Europeans than the 40 million who suffer from it directly: it also impacts their families, their communities and their health care systems. How are Europe’s governments rising to the challenge?
August 24, 2022
Solar Diesel Hybrid Power Systems Market Projected Value Of US$ 733.5 Mn, From Us$ 375.8 Mn In 2020, with Indexing A CAGR Of 6.9%.
August 24, 2022
Power Transmission Lines and Towers Market Projected Value Of US$ 38,208.7 Mn, From Us$ 31,536.4 Mn In 2020, with Indexing A CAGR Of 1.9%.
August 19, 2022
Film Dubbing Market is expected to reach USD 5,046.4 Million in 2030 with the highest Indexing CAGR Of 5.9% in the coming years.
August 17, 2022
600 MHz Nuclear Magnetic Resonance Spectrometer Market Projected Value Of US$ 165.6 Mn, From Us$ 112.3 Mn In 2020, with Indexing A CAGR Of 4%.
August 16, 2022
Conference call scheduled for 4:30 p.m. EDT today Exclusive distribution agreement signed with Shanghai Medtronic Zhikang Medical Devices Co. Ltd. for...
August 15, 2022
Conference call scheduled for 4:30 p.m. EDT today Exclusive distribution agreement signed with Shanghai Medtronic Zhikang Medical Devices Co. Ltd. for...
August 10, 2022
Power Conversion System (PCS) Electrochemical Energy Storage System Market Projected Value Of US$ 13,211.4 Mn, with Indexing A CAGR Of 24.9%.
May 18, 2022
Conference call scheduled for 8:30 am ET today hosted by management with guest Dr. Richard Fine Increased commercial activity in the U.S. and globally with...
April 2, 2022
Autoimmune toxicities, while common following treatment with cancer immunotherapies, are not well-characterized in patients treated with BRAF/MEK inhibitors. Emerging data suggest that autoimmune effects may be linked with superior responses to both treatment modalities; however, there is little evidence describing mechanisms of immune-related toxicity for patients on BRAF/MEK inhibitors. Here we describe the experience of a 59-year-old HLA-A2, A29, B27-positive male patient with recurrent/metas...